HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,130,687 | +15.4% | 27,061 | +2.6% | 0.00% | 0.0% |
Q2 2023 | $2,712,875 | -28.1% | 26,377 | -24.1% | 0.00% | -33.3% |
Q1 2023 | $3,773,099 | -91.4% | 34,757 | -90.9% | 0.00% | -91.7% |
Q4 2022 | $43,692,486 | -50.9% | 383,941 | -73.3% | 0.04% | -53.8% |
Q3 2022 | $88,966,000 | -10.0% | 1,437,480 | +16.0% | 0.08% | -3.7% |
Q2 2022 | $98,811,000 | -15.3% | 1,238,857 | +11.8% | 0.08% | +1.2% |
Q1 2022 | $116,593,000 | +10.6% | 1,108,197 | +13.3% | 0.08% | +19.4% |
Q4 2021 | $105,442,000 | -31.2% | 978,489 | -30.1% | 0.07% | -36.2% |
Q3 2021 | $153,366,000 | +68.3% | 1,400,088 | +43.8% | 0.10% | +69.4% |
Q2 2021 | $91,151,000 | -30.2% | 973,421 | -31.4% | 0.06% | -35.4% |
Q1 2021 | $130,662,000 | +60.5% | 1,419,618 | +27.5% | 0.10% | +52.4% |
Q4 2020 | $81,431,000 | -15.4% | 1,113,201 | -10.2% | 0.06% | -25.9% |
Q3 2020 | $96,308,000 | +40.1% | 1,239,808 | +0.2% | 0.08% | +30.8% |
Q2 2020 | $68,762,000 | +561.7% | 1,237,163 | +252.6% | 0.06% | +441.7% |
Q1 2020 | $10,392,000 | -42.1% | 350,843 | -29.2% | 0.01% | -29.4% |
Q4 2019 | $17,939,000 | +51.6% | 495,564 | +14.0% | 0.02% | +41.7% |
Q3 2019 | $11,832,000 | -21.9% | 434,539 | -31.0% | 0.01% | -20.0% |
Q2 2019 | $15,152,000 | – | 629,742 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |